Cargando…

Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genet...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsesmelis, Miltiadis, Tiwary, Kanishka, Steiger, Katja, Sperb, Nadine, Gerstenlauer, Melanie, Manfras, Uta, Maier, Harald J., Hermann, Patrick C., Chan, Lap Kwan, Wirth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471477/
https://www.ncbi.nlm.nih.gov/pubmed/34572768
http://dx.doi.org/10.3390/cancers13184541
_version_ 1784574476032147456
author Tsesmelis, Miltiadis
Tiwary, Kanishka
Steiger, Katja
Sperb, Nadine
Gerstenlauer, Melanie
Manfras, Uta
Maier, Harald J.
Hermann, Patrick C.
Chan, Lap Kwan
Wirth, Thomas
author_facet Tsesmelis, Miltiadis
Tiwary, Kanishka
Steiger, Katja
Sperb, Nadine
Gerstenlauer, Melanie
Manfras, Uta
Maier, Harald J.
Hermann, Patrick C.
Chan, Lap Kwan
Wirth, Thomas
author_sort Tsesmelis, Miltiadis
collection PubMed
description SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genetically modified KPC mouse model. In the absence of NEMO, KPC mice exhibited extended survival, which was accompanied by a strong reduction in the development of liver metastasis and ascites. Our study provides evidence for a detrimental role of the conventional NF-κB pathway in the survival of KPC mice and underlines the fact that NF-κB could be a therapeutic target against PDAC. ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) remains a largely incurable cancer type. Its high mortality is attributed to the lack of efficient biomarkers for early detection combined with its high metastatic properties. The aim of our study was to investigate the role of NF-κB signaling in the development and metastasis of PDAC. We used the well-established KPC mouse model, and, through genetic manipulation, we deleted NF-κB essential modulator (NEMO) in the pancreata of KPC mice. Interestingly, NEMO deletion altered the differentiation status of the primary tumor but did not significantly affect its development. However, in the absence of NEMO, the median survival of the mice was prolonged by 13.5 days (16%). In addition, examination of the liver demonstrated that, whereas KPC mice occasionally developed liver macro-metastasis, NEMO deletion completely abrogated this outcome. Further analysis of the tumor revealed that the expression of epithelial–mesenchymal transition (EMT) transcription factors was diminished in the absence of NEMO. Conclusively, our study provides evidence that NF-κB is dispensable for the progression of high-grade PanINs towards PDAC. In contrast, NF-κB signaling is essential for the development of metastasis by regulating the gene expression program of EMT.
format Online
Article
Text
id pubmed-8471477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84714772021-09-28 Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice Tsesmelis, Miltiadis Tiwary, Kanishka Steiger, Katja Sperb, Nadine Gerstenlauer, Melanie Manfras, Uta Maier, Harald J. Hermann, Patrick C. Chan, Lap Kwan Wirth, Thomas Cancers (Basel) Article SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is highly metastatic and is expected to be the second leading cause of cancer-related deaths in the USA by 2030. In the current study, we investigated the role of NEMO/NF-κB signaling in the development and metastasis of PDAC by using the genetically modified KPC mouse model. In the absence of NEMO, KPC mice exhibited extended survival, which was accompanied by a strong reduction in the development of liver metastasis and ascites. Our study provides evidence for a detrimental role of the conventional NF-κB pathway in the survival of KPC mice and underlines the fact that NF-κB could be a therapeutic target against PDAC. ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) remains a largely incurable cancer type. Its high mortality is attributed to the lack of efficient biomarkers for early detection combined with its high metastatic properties. The aim of our study was to investigate the role of NF-κB signaling in the development and metastasis of PDAC. We used the well-established KPC mouse model, and, through genetic manipulation, we deleted NF-κB essential modulator (NEMO) in the pancreata of KPC mice. Interestingly, NEMO deletion altered the differentiation status of the primary tumor but did not significantly affect its development. However, in the absence of NEMO, the median survival of the mice was prolonged by 13.5 days (16%). In addition, examination of the liver demonstrated that, whereas KPC mice occasionally developed liver macro-metastasis, NEMO deletion completely abrogated this outcome. Further analysis of the tumor revealed that the expression of epithelial–mesenchymal transition (EMT) transcription factors was diminished in the absence of NEMO. Conclusively, our study provides evidence that NF-κB is dispensable for the progression of high-grade PanINs towards PDAC. In contrast, NF-κB signaling is essential for the development of metastasis by regulating the gene expression program of EMT. MDPI 2021-09-10 /pmc/articles/PMC8471477/ /pubmed/34572768 http://dx.doi.org/10.3390/cancers13184541 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tsesmelis, Miltiadis
Tiwary, Kanishka
Steiger, Katja
Sperb, Nadine
Gerstenlauer, Melanie
Manfras, Uta
Maier, Harald J.
Hermann, Patrick C.
Chan, Lap Kwan
Wirth, Thomas
Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title_full Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title_fullStr Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title_full_unstemmed Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title_short Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice
title_sort deletion of nemo inhibits emt and reduces metastasis in kpc mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471477/
https://www.ncbi.nlm.nih.gov/pubmed/34572768
http://dx.doi.org/10.3390/cancers13184541
work_keys_str_mv AT tsesmelismiltiadis deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT tiwarykanishka deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT steigerkatja deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT sperbnadine deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT gerstenlauermelanie deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT manfrasuta deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT maierharaldj deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT hermannpatrickc deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT chanlapkwan deletionofnemoinhibitsemtandreducesmetastasisinkpcmice
AT wirththomas deletionofnemoinhibitsemtandreducesmetastasisinkpcmice